Newly developed PSG score improves patient selection for PSMA radiopharmaceutical therapy

by Society of Nuclear Medicine and Molecular ImagingRepresentative PET images of 6 patients classified as having high, intermediate, and low visual PSG scores. Credit: Society of Nuclear Medicine and

Updated on: January 13,2024

Newly developed PSG score improves patient selection for PSMA radiopharmaceutical therapy

by Society of Nuclear Medicine and Molecular ImagingRepresentative PET images of 6 patients classified as having high, intermediate, and low visual PSG scores. Credit: Society of Nuclear Medicine and

Updated on:January 13,2024

Categorizing the epigenetic hallmarks that define cancer

byJosep Carreras Leukaemia Research InstituteThe epigenetic hallmarks of cancer. The illustration depicts the six epigenetic hallmarks that are shared among human malignancies affecting Q8 DNA m

Updated on: October 26,2024

Categorizing the epigenetic hallmarks that define cancer

byJosep Carreras Leukaemia Research InstituteThe epigenetic hallmarks of cancer. The illustration depicts the six epigenetic hallmarks that are shared among human malignancies affecting Q8 DNA m

Updated on:October 26,2024

Research reveals new possibilities to improve treatment of endometrial carcinoma

by Ana María Rodríguez,Baylor College of MedicineCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.07.007Endometrial carcinoma, a cancer of the lining of the uterus, is the most co

Updated on: July 02,2024

Research reveals new possibilities to improve treatment of endometrial carcinoma

by Ana María Rodríguez,Baylor College of MedicineCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.07.007Endometrial carcinoma, a cancer of the lining of the uterus, is the most co

Updated on:July 02,2024

New immunotherapy holds promise for ovarian cancer

byKarolinska InstitutetIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) a

Updated on: January 12,2024

New immunotherapy holds promise for ovarian cancer

byKarolinska InstitutetIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) a

Updated on:January 12,2024

Tiny tumor model recreates cancer metastasis

by Rachel Harrison,New York UniversityClusters of about a hundred tumor cells labeled with red fluorescence were grown inside a transparent jelly-like structure and surrounded by immune cells ca

Updated on: November 08,2024

Tiny tumor model recreates cancer metastasis

by Rachel Harrison,New York UniversityClusters of about a hundred tumor cells labeled with red fluorescence were grown inside a transparent jelly-like structure and surrounded by immune cells ca

Updated on:November 08,2024

The 'wrong' connective tissue cells signal worse prognosis for breast cancer patients

by Lund UniversityDifferent types of fibroblasts in breast tumour tissue. Credit: Chris MadsenIn certain forms of cancer, connective tissue forms around and within the tumour. One previously unpr

Updated on: March 13,2024

The 'wrong' connective tissue cells signal worse prognosis for breast cancer patients

by Lund UniversityDifferent types of fibroblasts in breast tumour tissue. Credit: Chris MadsenIn certain forms of cancer, connective tissue forms around and within the tumour. One previously unpr

Updated on:March 13,2024

Model suggests increased use of Paxlovid could cut hospitalizations, deaths and costs

by University of Texas at AustinEpidemiology researchers have found that if just 20% of symptomatic COVID cases was treated with Paxlovid, it would reduce deaths, hospitalizations and costs. Cred

Updated on: May 06,2024

Model suggests increased use of Paxlovid could cut hospitalizations, deaths and costs

by University of Texas at AustinEpidemiology researchers have found that if just 20% of symptomatic COVID cases was treated with Paxlovid, it would reduce deaths, hospitalizations and costs. Cred

Updated on:May 06,2024

Selinexor for multiple myeloma receives accelerated FDA approval

by H. Lee Moffitt Cancer Center & Research InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0A first-in-class d

Updated on: May 09,2024

Selinexor for multiple myeloma receives accelerated FDA approval

by H. Lee Moffitt Cancer Center & Research InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0A first-in-class d

Updated on:May 09,2024

Cancer in those under 50 is rising, globally. Why?

by Siobhan Glavey,The ConversationCredit: AI-generated imageWe know what we need to do to reduce our risk of getting cancer, right? Wear SPF, stop smoking, avoid processed foods, keep fit, lose

Updated on: January 02,2024

Cancer in those under 50 is rising, globally. Why?

by Siobhan Glavey,The ConversationCredit: AI-generated imageWe know what we need to do to reduce our risk of getting cancer, right? Wear SPF, stop smoking, avoid processed foods, keep fit, lose

Updated on:January 02,2024

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-

Updated on: April 12,2024

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-

Updated on:April 12,2024

Clinical trial finds combination hormone therapy delivers superior prostate cancer treatment

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainCombining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better tha

Updated on: May 09,2024

Clinical trial finds combination hormone therapy delivers superior prostate cancer treatment

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainCombining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better tha

Updated on:May 09,2024

Treating the TOTAL patient: clinical trial reduces relapse

by St. Jude Children's Research HospitalSima Jeha, M.D., of the St. Jude Departments of Oncology and Global Pediatric Medicine, and Ching-Hon Pui, M.D., chair of the St. Jude Department of On

Updated on: April 10,2024

Treating the TOTAL patient: clinical trial reduces relapse

by St. Jude Children's Research HospitalSima Jeha, M.D., of the St. Jude Departments of Oncology and Global Pediatric Medicine, and Ching-Hon Pui, M.D., chair of the St. Jude Department of On

Updated on:April 10,2024